タンパク質・抗体・核酸送達技術の世界市場:規模・現状・予測2019-2025

QYResearchが発行した調査報告書(QYR20FB07578)
◆英語タイトル:Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, Status and Forecast 2019-2025
◆商品コード:QYR20FB07578
◆発行会社(リサーチ会社):QYResearch
◆発行日:2019年12月4日(※2024年版があります。お問い合わせください。)
◆ページ数:97
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,900 ⇒換算¥577,200見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD5,850 ⇒換算¥865,800見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD7,800 ⇒換算¥1,154,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

※当調査レポートでは、タンパク質・抗体・核酸送達技術の世界市場について調査・分析し、タンパク質・抗体・核酸送達技術の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別(HEPtune®テクノロジー、Intravail®テクノロジー、RapidMist™、TheraKineテクノロジー、Arestat™テクノロジー、DelSiTech™シリカマトリックス、ImSus®テクノロジー、PLEX™テクノロジー、ENHANZE®テクノロジー)、用途別(タンパク質送達、核酸送達、送達抗体)、地域別(北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米)に区分して市場規模を算出しました。


・レポートの概要
・世界のタンパク質・抗体・核酸送達技術市場動向
・主要企業別マーケットシェア
・タンパク質・抗体・核酸送達技術の種類別市場規模2014-2019
(HEPtune®テクノロジー、Intravail®テクノロジー、RapidMist™、TheraKineテクノロジー、Arestat™テクノロジー、DelSiTech™シリカマトリックス、ImSus®テクノロジー、PLEX™テクノロジー、ENHANZE®テクノロジー)
・タンパク質・抗体・核酸送達技術の用途別市場規模2014-2019
(タンパク質送達、核酸送達、送達抗体)
・タンパク質・抗体・核酸送達技術の北米市場:主要企業・種類別/用途別市場規模
・タンパク質・抗体・核酸送達技術のヨーロッパ市場:主要企業・種類別/用途別市場規模
・タンパク質・抗体・核酸送達技術の中国市場:主要企業・種類別/用途別市場規模
・タンパク質・抗体・核酸送達技術の日本国内市場:主要企業・種類別/用途別市場規模
・タンパク質・抗体・核酸送達技術の東南アジア市場:主要企業・種類別/用途別市場規模
・タンパク質・抗体・核酸送達技術のインド市場:主要企業・種類別/用途別市場規模
・タンパク質・抗体・核酸送達技術の中南米市場:主要企業・種類別/用途別市場規模
・主要企業のプロフィール
(Aphios、Arbutus Biopharma、Camurus、ConjuChem、InnoCore Pharmaceuticals、LATITUDE Pharmaceuticals)
・タンパク質・抗体・核酸送達技術の市場規模予測2019-2025
(種類別、用途別、地域別市場予測)
・アナリストの観点・結論
...
【レポートの概要】

Novel Technologies for Delivery of Proteins, Antibodies and Nucleic AcidsGiven their high target specificity and limited toxicity compared to small molecule drugs, biotherapeutics have revolutionized treatment paradigms in a myriad of clinical conditions, including metabolic disorders, cancer, neurological disorders and autoimmune diseases. And apply a variety of new technologies.
In 2018, the global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Technologies for Delivery of Proteins, Antibodies and Nucleic Acids development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
Aphios
Arbutus Biopharma
Camurus
ConjuChem
InnoCore Pharmaceuticals
LATITUDE Pharmaceuticals

Market segment by Type, the product can be split into
HEPtune® Technology
Intravail® Technology
RapidMist™
TheraKine Technology
Arestat™ Technology
DelSiTech™ Silica Matrix
ImSus® Technology
PLEX™ Technology
ENHANZE® Technology

Market segment by Application, split into
Delivery of Protein
Delivery of Nucleic Acids
Delivery Antibody

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids status, future forecast, growth opportunity, key market and key players.
To present the Technologies for Delivery of Proteins, Antibodies and Nucleic Acids development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Growth Rate by Type (2014-2025)
1.4.2 HEPtune® Technology
1.4.3 Intravail® Technology
1.4.4 RapidMist™
1.4.5 TheraKine Technology
1.4.6 Arestat™ Technology
1.4.7 DelSiTech™ Silica Matrix
1.4.8 ImSus® Technology
1.4.9 PLEX™ Technology
1.4.10 ENHANZE® Technology
1.5 Market by Application
1.5.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Application (2019-2025)
1.5.2 Delivery of Protein
1.5.3 Delivery of Nucleic Acids
1.5.4 Delivery Antibody
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size
2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Growth Trends by Regions
2.2.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions (2019-2025)
2.2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis

3 Market Share by Key Players
3.1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by by Players
3.1.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by by Players (2014-2019)
3.1.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by by Players (2014-2019)
3.1.3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Concentration Ratio (CR5 and HHI)
3.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players Head office and Area Served
3.3 Key Players Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Product/Solution/Service
3.4 Date of Enter into Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type (2014-2019)
4.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application (2014-2019)

5 North America
5.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
5.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in North America
5.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
5.4 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application

6 Europe
6.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
6.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Europe
6.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
6.4 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application

7 China
7.1 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
7.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in China
7.3 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
7.4 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application

8 Japan
8.1 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
8.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Japan
8.3 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
8.4 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
9.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Southeast Asia
9.3 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
9.4 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application

10 India
10.1 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
10.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in India
10.3 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
10.4 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application

11 Central & South America
11.1 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (2014-2019)
11.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Key Players in Central & South America
11.3 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Type
11.4 Central & South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Application

12 International Players Profiles
12.1 Aphios
12.1.1 Aphios Company Details
12.1.2 Company Description and Business Overview
12.1.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.1.4 Aphios Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019))
12.1.5 Aphios Recent Development
12.2 Arbutus Biopharma
12.2.1 Arbutus Biopharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.2.4 Arbutus Biopharma Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019)
12.2.5 Arbutus Biopharma Recent Development
12.3 Camurus
12.3.1 Camurus Company Details
12.3.2 Company Description and Business Overview
12.3.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.3.4 Camurus Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019)
12.3.5 Camurus Recent Development
12.4 ConjuChem
12.4.1 ConjuChem Company Details
12.4.2 Company Description and Business Overview
12.4.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.4.4 ConjuChem Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019)
12.4.5 ConjuChem Recent Development
12.5 InnoCore Pharmaceuticals
12.5.1 InnoCore Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.5.4 InnoCore Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019)
12.5.5 InnoCore Pharmaceuticals Recent Development
12.6 LATITUDE Pharmaceuticals
12.6.1 LATITUDE Pharmaceuticals Company Details
12.6.2 Company Description and Business Overview
12.6.3 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Introduction
12.6.4 LATITUDE Pharmaceuticals Revenue in Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Business (2014-2019)
12.6.5 LATITUDE Pharmaceuticals Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

...

【掲載企業】

Aphios、Arbutus Biopharma、Camurus、ConjuChem、InnoCore Pharmaceuticals、LATITUDE Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ タンパク質・抗体・核酸送達技術の世界市場:規模・現状・予測2019-2025(Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size, Status and Forecast 2019-2025)]についてメールでお問い合わせはこちらでお願いします。